Back to Search
RAQUEL MILLET, MD
MD
Pediatrics Physician
NPI: 1902368384Individual
Specialties, Licenses & Credentials
Pediatrics PhysicianPrimary
Pediatrics
Code: 208000000X
D0094636(MD)
Research & Publications (13)
Design, synthesis and biological evaluation of substituted dioxodibenzothiazepines and dibenzocycloheptanes as farnesyltransferase inhibitors.
PMID 17827015·Bioorg Med Chem Lett·2007
7-preclinical
Pharmacomodulations around the 4-oxo-1,4-dihydroquinoline-3-carboxamides, a class of potent CB2-selective cannabinoid receptor ligands: consequences in receptor affinity and functionality.
PMID 17915849·J Med Chem·2007
7-preclinical
Synthesis of a novel conformationally restricted Val-Phe dipeptidomimetic.
PMID 15948143·J Pept Sci·2006
8-other
Solid-phase synthesis and pharmacological evaluation of a library of peptidomimetics as potential farnesyltransferase inhibitors: an approach to new lead compounds.
PMID 16647166·Eur J Med Chem·2006
8-other
Novel 4-oxo-1,4-dihydroquinoline-3-carboxamide derivatives as new CB2 cannabinoid receptors agonists: synthesis, pharmacological properties and molecular modeling.
PMID 16392793·J Med Chem·2006
8-other
Novel N-(4-Piperidinyl)benzamide antimalarials with mammalian protein farnesyltransferase inhibitory activity.
PMID 16204993·Chem Pharm Bull (Tokyo)·2005
7-preclinical
In vitro and in vivo evaluation of two rational-designed nonpeptidic farnesyltransferase inhibitors on HT29 human colon cancer cell lines.
PMID 16925112·Oncol Res·2005
7-preclinical
Synthesis of 5-nitro-2-furancarbohydrazides and their cis-diamminedichloroplatinum complexes as bitopic and irreversible human thioredoxin reductase inhibitors.
PMID 16250662·J Med Chem·2005
7-preclinical
Antitrypanosomal activities and cytotoxicity of 5-nitro-2-furancarbohydrazides.
PMID 12443785·Bioorg Med Chem Lett·2002
7-preclinical
Novel potent substance P and neurokinin A receptor antagonists. Conception, synthesis and biological evaluation of indolizine derivatives.
PMID 12110311·Bioorg Med Chem·2002
7-preclinical
A flexible approach to the design of new potent substance P receptor ligands.
PMID 11480541·J Pharm Pharmacol·2001
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1800 ORLEANS ST
BALTIMORE, MD 21287 - Phone
- (410) 955-5000
Quick Facts
- NPI
- 1902368384
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 13
Are you this provider?
Claim Your Profile